USPTO 2015–2025 USPTO PatentsView US Corporation

Peptilogics, Inc.

USPTO PatentsView assignee record — 11 granted patents across 9 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06N (COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS).

11
Total patents granted
9
CPC technology areas
23.4
Avg claims per patent
5-year filing velocity

Portfolio overview

Peptilogics, Inc. has been granted 11 US utility patents between 2021 and 2024, placing Peptilogics, Inc. at rank #24,992 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.4 claims per patent with primary concentration in G06N (COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS). As a US Corporation, Peptilogics, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 53.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Peptilogics, Inc.'s 23.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Peptilogics, Inc. against peers pursuing similar technology classes.

How does Peptilogics compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Peptilogics holds 11 patents — placing it at rank #24,992 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2021–2024

0123456 2021202220232024 3
USPTO utility patent grants by year · 2021–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Peptilogics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 9.1%
2022 5 45.5%
2023 2 18.2%
2024 3 27.3%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex

Where it ranks

Overall rank by patents

#24,992

Across all tracked assignees

Innovation Score

53.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Peptilogics, Inc. hold?
Peptilogics, Inc. holds 11 US granted patents filed between 2021 and 2024, spanning 9 technology areas.
What is Peptilogics, Inc.'s Innovation Score?
Peptilogics, Inc. has an Innovation Score of 53.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Peptilogics, Inc. focus on?
Peptilogics, Inc.'s top technology area is G06N (COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS) with 11 patents. The company has filed patents in 9 CPC subclasses total.
Is Peptilogics, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Peptilogics, Inc..
What does claim depth mean for Peptilogics, Inc.'s patents?
Peptilogics, Inc.'s patents average 23.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Peptilogics, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope